Researchers use viscous seaweed to treat retinal detachment

News
Article

The effort led to the creation of an artificial vitreous body for treating retinal detachment. This solution is based on a natural carbohydrate derived from algae.

Seaweed floating in water Image Credit: AdobeStock/divedog

Image Credit: AdobeStock/divedog

Researchers at Pohang University of Science and Technology (POSTECH) have published results of a study exploring the use of alginate for the treatment of retinal detachment.

The study, a collaborative effort that includes researchers from the Department of Chemical Engineering, School of Convergence Science and Technology, and the Department of Chemical Engineering at POSTECH and the Dong-A University Hospital's Department of Ophthalmology, was published in Biomaterials.1

The researchers’ work has led to the creation of an artificial vitreous body for treating retinal detachment. This solution is based on a natural carbohydrate derived from algae.

According to a POSTECH news release, the vitreous body is a gel-like substance that occupies the space between the lens and retina, contributing to the eye's structural integrity. Retinal detachment occurs when the retina separates from the inner wall of the eye and moves into the vitreous cavity, leading to detachment and potentially resulting in blindness in severe cases. While a common approach involves removing the vitreous body and substituting it with medical intraocular fillers like expandable gas or silicone oil, these fillers have been associated with various side effects.2

The researchers addressed these issues by using a modified form of alginate, a natural carbohydrate sourced from algae. Alginate, also known as alginic acid, is widely utilized in various industries, including food and medicine, for its ability to create viscous products. In this research, the team crafted a medical composite hydrogel based on alginate, offering a potential alternative for vitreous replacement.

The hydrogel, which has high biocompatibility and optical properties akin to authentic vitreous body, enables patients to preserve their vision post-surgery. Its distinctive viscoelasticity effectively regulates fluid dynamics within the eye, contributing to retinal stabilization and the elimination of air bubbles.1

To validate the hydrogel's stability and effectiveness, researchers conducted experiments using animal models, specifically rabbit eyes, which closely resemble human eyes in structure, size, and physiological response. Implanting the hydrogel into rabbit eyes demonstrated its success in preventing the recurrence of retinal detachment, maintaining stability, and functioning well over an extended period without any adverse effects.2

POSTECH’s Hyung Joon Cha, PhD, who led the study, noted in the news release that there is a correlation between retinal detachment and severe myopia and the prevalence of retinal detachment is increasing, particularly in young people.

“The incidence of retinal detachment cases in Korea rose by 50% in 2022 compared to 2017,” he said. “Our team will enhance and progress the technology to make the hydrogel suitable for practical use in real-world eye care through ongoing research.”

“The worldwide market for intraocular fillers is expanding at a rate of 3% per year,” said Woo Jin Jeong, MD, PhD, from the Dong-A University Hospital. “We anticipate that the hydrogel we've created will prove beneficial in upcoming vitreoretinal surgeries."

The research was sponsored by the Korea Medical Device Development Fund and the Mid-Career Research Program of the National Research Foundation of Korea.2

References:
  1. Geunho Choi, Seoung Hyuan An, Joe-Won Choi, Mee Sook Rho, Woo Chan Park, Woo Jin Jeonh, Hyung Joon Cha. Injectable alginate-based in situ self-healable transparent hydrogel as a vitreous substitute with a tamponading function, Biomaterials, Volume 305, Published March 2024, 122459, ISSN 0142-9612. DOI: https://doi.org/10.1016/j.biomaterials.2023.122459
  2. Treatment for blindness-causing retinal detachment using viscous seaweed. EurekAlert! Accessed March 27, 2024. https://www.eurekalert.org/news-releases/1039024
Recent Videos
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
Optometrists local to the Los Angeles area overview their efforts to continue providing support to patients affected by January's wildfires.
Brianna Rhue, OD, FAAO, FSLS, reviewed key takeaways from The Future of Myopia Management: Perspectives from Leading Experts talk from SECO 2025.
Dr. Julie Rodman discusses retina, imaging, and posterior segment in SECO presentations
Robert L. Stamper, MD, overviews his optometric track talk titled Objective Perimetry - Can you see it? at this year's Glaucoma 360 meeting.
Dr. Julie Rodman previews her SECO presentations
Yvonne Ou, MD, outlined lifestyle modifications for glaucoma management that have proven beneficial, including yoga and cycling.
Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.
John Berdahl, MD, overviews the new FYXS Ocular Pressure Adjusting Pump and HERCULES trial at the Glaucoma 360 meeting.
© 2025 MJH Life Sciences

All rights reserved.